Kincell Bio collaborates with cell therapy developers by using considerable scientific experience and industry understanding.
Kincell Bio has raised $22.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2025.
Kincell Bio's investors include NewSpring, Kineticos Life Sciences, Kineticos Ventures.
Kincell Bio is headquartered in Gainesville, United States.
Kincell Bio collaborates with cell therapy developers by using considerable scientific experience and industry understanding.
Kincell Bio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kincell Bio — Funding & Investors." VCBacked, May 15, 2025, https://www.vcbacked.co/company/kincell-bio. Accessed August 14, 2026.
VCBacked. (2025). Kincell Bio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/kincell-bio
{{cite web |title=Kincell Bio — Funding & Investors |url=https://www.vcbacked.co/company/kincell-bio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated